5th Annual Bayesian Biostatistics Conference

Sponsored in part by the Department of Biostatistics at The University of Texas MD Anderson Cancer Center

Monday, January 23, 2012 – Wednesday, January 25, 2012

Robert C. Hickey Auditorium
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd, Houston, Texas 77030

Program Committee

Donald A. Berry, PhD, Co-Chair; The University of Texas MD Anderson Cancer Center
Telba Z. Irony, PhD, Co-Chair; CDRH, U.S. Food and Drug Administration
Brenda L. Gaydos, PhD; Eli Lilly and Company
Lurdes Inoue, PhD; University of Washington
Jeffrey D. Maca, PhD; Novartis Pharmaceutical
Jeffrey S. Morris, PhD; The University of Texas MD Anderson Cancer Center
Dalene Stangl, PhD; Duke University

Program Highlights

Short course: Reproducible Research
Frank E. Harrell, Jr., PhD
Professor and Chair, Department of Biostatistics
Vanderbilt University School of Medicine

Keynote presentation: Bayesian Adjustment for Multiplicity and Subgroup Analysis (pdf)
James O. Berger, PhD
Arts and Sciences Professor of Statistics
Department of Statistical Science
Duke University

Session Topic: Multiple Comparisons

Multivariate Bayesian logistic regression for clinical safety data (pdf)
William DuMouchel, PhD
Chief Statistical Scientist
Oracle Health Sciences
Nonparametric relevance determination: Identifying genes that matter (pdf)
Wesley O. Johnson, PhD
Professor, Department of Statistics
University of California at Irvine
A Bayesian subgroup analysis with a zero-enriched Polya urn scheme (pdf)
Peter Müller, PhD
Professor, Department of Mathematics
The University of Texas at Austin

Session Topic: Missing Data

Thomas R. Belin, PhD
Professor of Biostatistics & Psychiatry and Biobehavioral Sciences
School of Public Health
University of California at Los Angeles
Michael J. Daniels, ScD
Professor and Chair, Department of Statistics
University of Florida at Gainesville
Treatment discontinuation and missing data in clinical trials: Ignorability and identifiability issues (pdf)
Roderick Little, PhD
Richard D. Remington Collegiate Professor of Biostatistics
Professor, Department of Statistics, School of Public Health
University of Michigan

Session Topic: Bayesian Methods for Evidence Synthesis to Drive Decision Making in Drug Development

Hajun Ma, PhD
Senior Statistical Manager
Global Safety and Independent Biostatistics Group
Amgen
Fanni Natanegara, PhD
Senior Research Scientist
Eli Lilly and Company
John Scott, PhD
Statistician
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration

Optimization of dynamic treatment regimes for recurrent diseases (pdf)
Xuelin Huang, PhD
Associate Professor
Department of Biostatistics
MD Anderson Cancer Center
Bayesian 2-stage design in phase II clinical trials with time-to-event endpoint:A simulation-based decision-theoretic approach (pdf)
Lili Zhao, PhD
Research Investigator
Biostatistics Department
University of Michigan
Evaluate the probability of study success through Bayesian evidence synthesis techniques (pdf)
Hoada Fu, PhD
Statistician
Eli Lilly and Company

Session Topic: Bayesian Methods in Trial Design and Analysis

David Ohlssen, PhD
Novartis Pharmaceutical
William Prucka, PhD
Eli Lilly and Company

Session Topic: Incorporating Biological Structure in Bayesian Modeling: Networks and Pathway Analysis

A spatial model for the analysis of large-scale neuroimaging data (pdf)
F. DuBois Bowman, PhD
Associate Professor
Department of Biostatistics and Bioinformatics
Director, Center for Biomedical Imaging Studies
Emory University
Multi-way Gaussian graphical models with application to multivariate lattice data (pdf)
Adian Dobra, PhD
Assistant Professor, Department of Statistics
and Department of Biobehavioral Nursing & Health Systems
University of Washington
A Bayesian graphical model for single-cell cytometry data (pdf)
Yuan Ji, PhD
Associate Professor, Department of Biostatistics
MD Anderson Cancer Center
Hongzhe Li, PhD
Professor of Biostatistics
Perelman School of Medicine
University of Pennsylvania